These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3927693)
21. Impact of diagnosis related groups on medical practice. May JJ Am J Cardiol; 1985 Aug; 56(5):16C-26C. PubMed ID: 3927694 [TBL] [Abstract][Full Text] [Related]
22. [Quality of medical database to valorize the DRG model by ISA cost indicators]. Holstein J; Taright N; Lepage E; Razafimamonjy J; Duboc D; Feldman L; Hittinger L; Lavergne T; Chatellier G Rev Epidemiol Sante Publique; 2002 Dec; 50(6):593-603. PubMed ID: 12515929 [TBL] [Abstract][Full Text] [Related]
23. Prospective payment for hospital costs using diagnosis-related groups: will cost inflation be reduced? Keith SN J Natl Med Assoc; 1983 Jun; 75(6):609, 612-4, 619. PubMed ID: 6410079 [TBL] [Abstract][Full Text] [Related]
24. The financial impact of Medicare diagnosis-related groups. Effect upon hospitals receiving cardiac patients referred for tertiary care. Thomas F; Fox J; Clemmer TP; Orme JF; Vincent GM; Menlove RL Chest; 1987 Mar; 91(3):418-23. PubMed ID: 3102172 [TBL] [Abstract][Full Text] [Related]
25. DRG prospective, "all payor systems," financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs. Muñoz E; Barrau L; Goldstein J; Benacquista T; Mulloy K; Wise L Chest; 1988 Oct; 94(4):855-61. PubMed ID: 3139375 [TBL] [Abstract][Full Text] [Related]
26. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK; Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091 [TBL] [Abstract][Full Text] [Related]
27. Clinical redesign using all patient refined diagnosis related groups. Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular medicine in the updated German diagnosis-related groups (G-DRG) for the year 2004]. Roeder N; Fürstenberg T; Bunzemeier H; Reinecke H Z Kardiol; 2004 Apr; 93(4):266-77. PubMed ID: 15085371 [TBL] [Abstract][Full Text] [Related]
29. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Eisenstein EL; Leon MB; Kandzari DE; Mauri L; Edwards R; Kong DF; Cowper PA; Anstrom KJ; JACC Cardiovasc Interv; 2009 Dec; 2(12):1199-207. PubMed ID: 20129546 [TBL] [Abstract][Full Text] [Related]
30. Reimbursement under DRGs: implementation in New Jersey. Davies RH; Westfall G Health Serv Res; 1983; 18(2 Pt 1):233-47. PubMed ID: 6409841 [TBL] [Abstract][Full Text] [Related]
31. Impact of case type, length of stay, institution type, and comorbidities on Medicare diagnosis-related group reimbursement for adult spinal deformity surgery. Nunley PD; Mundis GM; Fessler RG; Park P; Zavatsky JM; Uribe JS; Eastlack RK; Chou D; Wang MY; Anand N; Frank KA; Stone MB; Kanter AS; Shaffrey CI; Mummaneni PV; Neurosurg Focus; 2017 Dec; 43(6):E11. PubMed ID: 29191102 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of revascularization strategies: the ASCERT study. Zhang Z; Kolm P; Grau-Sepulveda MV; Ponirakis A; O'Brien SM; Klein LW; Shaw RE; McKay C; Shahian DM; Grover FL; Mayer JE; Garratt KN; Hlatky M; Edwards FH; Weintraub WS J Am Coll Cardiol; 2015 Jan; 65(1):1-11. PubMed ID: 25572503 [TBL] [Abstract][Full Text] [Related]
33. The economic impact of alternative cardiac care unit treatment practices. Greenberg JA; Kropf R Health Serv Res; 1982; 17(1):45-59. PubMed ID: 6804415 [TBL] [Abstract][Full Text] [Related]
34. Hospital cost control in Norway: a decade's experience with prospective payment. Crane TS Public Health Rep; 1985; 100(4):406-17. PubMed ID: 3927385 [TBL] [Abstract][Full Text] [Related]
35. Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Hirth RA; Held PJ; Orzol SM; Dor A Health Serv Res; 1999 Feb; 33(6):1567-92. PubMed ID: 10029498 [TBL] [Abstract][Full Text] [Related]
36. Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities. Munoz E; Cohen JR; Goldstein J; Benacquista T; Mulloy K; Wise L Ann Vasc Surg; 1989 Apr; 3(2):170-6. PubMed ID: 2504266 [TBL] [Abstract][Full Text] [Related]
37. Managing specialty care in an era of heightened accountability: emphasizing quality and accelerating savings. Peabody JW; Huang X; Shimkhada R; Rosenthal M Am J Manag Care; 2015 Apr; 21(4):284-92. PubMed ID: 26014467 [TBL] [Abstract][Full Text] [Related]
38. New product opportunities with DRGs. Anthony FH Hosp Pharm; 1985 Jan; 20(1):10-1. PubMed ID: 10310980 [TBL] [Abstract][Full Text] [Related]
39. Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Halpern NA; Pastores SM Crit Care Med; 2010 Jan; 38(1):65-71. PubMed ID: 19730257 [TBL] [Abstract][Full Text] [Related]
40. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]